Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

In Brief: Pharmacia & Upjohn's Motrin IB Sinus

This article was originally published in The Tan Sheet

Executive Summary

Pharmacia & Upjohn's Motrin IB Sinus: Will return to stores "within the next two to four weeks," the company says. The product will be reintroduced in 30-count "bonus packs" at a suggested average retail price of $4.37. Pharmacia & Upjohn took the ibuprofen/pseudoephedrine combination off the market about a year ago after losing a patent infringement suit filed against the company and McNeil by Rich-Vicks. The decision was reversed by a federal appellate court ruling ("The Tan Sheet" Jan. 22, p. 1). According to Pharmacia & Upjohn, Motrin IB Sinus had a 2.5% market share among "all sinus remedies" in 1994...
Advertisement
Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

PS085489

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel